The additive value of biomarkers to clinical risk scores in acute coronary syndrome. Are biomarkers really ready for real world usage?

Tello-Montoliu, Antonio; Marín, Francisco; Roldán, Vanessa; Lip, Gregory Y. H.
February 2010
Heart;Feb2010, Vol. 96 Issue 3, p227
Academic Journal
The article reports on the significance of biomarkers on treating acute coronary syndrome (ACS) patients.


Related Articles

  • Lipocalin (LCN) 2 Mediates Pro-Atherosclerotic Processes and Is Elevated in Patients with Coronary Artery Disease. Oberoi, Raghav; Bogalle, Eskindir P.; Matthes, Lukas A.; Schuett, Harald; Koch, Ann-Kathrin; Grote, Karsten; Schieffer, Bernhard; Schuett, Jutta; Luchtefeld, Maren // PLoS ONE;9/14/2015, Vol. 10 Issue 9, p1 

    Background: Lipocalin (LCN) 2 is associated with multiple acute and chronic inflammatory diseases but the underlying molecular and cellular mechanisms remain unclear. Here, we investigated whether LCN2 is released from macrophages and contributes to pro-atherosclerotic processes and whether...

  • Polymorphisms in MTHFR, MS and CBS genes and premature acute myocardial infarction in a Pakistani population. Perwaiz Iqbal, Mohammad; Iqbal, Khalida; Khan Tareen, Asal; Parveen, Siddiqa; Mehboobali, Naseema; Haider, Ghulam; Perwaiz Iqbal, Saleem // Pakistan Journal of Pharmaceutical Sciences;Nov2016, Vol. 29 Issue 6, p1901 

    High prevalence of premature coronary heart disease in Pakistanis compared to other populations points towards the genetic predisposition of this population to develop this disease. Since no investigations have been carried out in Pakistan to study the relationship of polymorphisms in genes...

  • Parametric imaging of myocardial viability using O-labelled water and PET/CT: comparison with late gadolinium-enhanced CMR. Haan, Stefan; Harms, Hendrik; Lubberink, Mark; Allaart, Cornelis; Danad, Ibrahim; Chen, Weena; Diamant, Michaela; Rossum, Albert; Iida, Hidehiro; Lammertsma, Adriaan; Knaapen, Paul // European Journal of Nuclear Medicine & Molecular Imaging;Aug2012, Vol. 39 Issue 8, p1240 

    Purpose: The perfusable tissue index (PTI) is a marker of myocardial viability. Recent technological advances have made it possible to generate parametric PTI images from a single [O]HO PET/CT scan. The purpose of this study was to validate these parametric PTI images. Methods: The study...

  • Increased Serum Cathepsin K in Patients with Coronary Artery Disease. Xiang Li; Yuzi Li; Jiyong Jin; Dehao Jin; Lan Cui; Xiangshan Li; Yanna Rei; Haiying Jiang; Guangxian Zhao; Guang Yang; Enbo Zhu; Yongshan Nan; Xianwu Cheng // Yonsei Medical Journal;Jun2014, Vol. 55 Issue 4, p912 

    Purpose: Cathepsin K is a potent collagenase implicated in human and animal atherosclerosis-based vascular remodeling. This study examined the hypothesis that serum CatK is associated with the prevalence of coronary artery disease (CAD). Materials and Methods: Between January 2011 and December...

  • Plasma endoglin as a marker to predict cardiovascular events in patients with chronic coronary artery diseases. Ikemoto, Tomokazu; Hojo, Yukihiro; Kondo, Hideyuki; Takahashi, Nozomu; Hirose, Masahiro; Nishimura, Yoshioki; Katsuki, Takaaki; Shimada, Kazuyuki; Kario, Kazuomi // Heart & Vessels;Jul2012, Vol. 27 Issue 4, p344 

    Recent clinical studies have revealed that the expression of endoglin, an accessory protein for the TGF-β receptor, is increased in patients with atherosclerotic diseases. The plasma endoglin level is thought to represent endothelial activation, inflammation, and senescence. To clarify the...

  • High clinical accuracy of asymmetric dimethylarginine and symmetric dimethylarginine in patients with ischemic heart disease. Djordjević, B.; Pavlović, R.; Ćosić, V.; Deljanin-Ilić, M.; Ristić, T.; Krstić, N.; Jevtović-Stoimenov, T. // Amino Acids;Dec2012, Vol. 43 Issue 6, p2293 

    Elevated plasma concentrations of asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) were found in various clinical settings including coronary heart disease. To assess ADMA and SDMA diagnostic validity in patients with different stages of ischemic heart disease, we studied...

  • Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: Insights from the Heart and Soul Study. Grenon, S Marlene; Vittinghoff, Eric; Owens, Christopher D; Conte, Michael S; Whooley, Mary; Cohen, Beth E // Vascular Medicine;Aug2013, Vol. 18 Issue 4, p176 

    Among patients with coronary artery disease (CAD), those with peripheral artery disease (PAD) have a greater vulnerability to cardiovascular (CV) events than those with CAD alone. In a prospective cohort study of patients with CAD, we evaluated potential mechanisms that might explain the adverse...

  • Levels of Circulating Biomarkers at Rest and after Exercise in Coronary Artery Disease Patients. Danzig, V.; Míková, B.; Kuchynka, P.; Benáková, H.; Zima, T.; Kittnar, O.; Škrha, J.; Linhart, A.; Kalousová, M. // Physiological Research;2010, Vol. 59 Issue 3, p385 

    As traditional risk factors are unable to fully explain the pathogenesis of coronary artery disease (CAD), novel mechanisms became a target of many investigations. Our aim was to study the response of selected markers to physical exercise. High-sensitive C-reactive protein (hs-CRP), matrix...

  • The coronary calcium treadmill test: A new approach to the initial workup of patients with suspected coronary artery disease. Rozanski, Alan; Cohen, Randy; Uretsky, Seth // Journal of Nuclear Cardiology;Oct2013, Vol. 20 Issue 5, p719 

    Due to the growth of cardiac testing and increasing cost of cardiovascular healthcare, the development of more cost-effective strategies has now become a dominant issue regarding future utilization of cardiac imaging procedures. To that end, we review the potential of combining two relatively...


Read the Article


Sign out of this library

Other Topics